The Editorial Board of Journal of Cancer Clinical Trials is overwhelmed by the response and eagerness of the academic and research contributors to publish with the journal and take part in the year-long celebrations. During this year we look forward to taking some initiatives that would encourage and reward our prospective audience which include research scientists, decision-makers and a range of professionals in the oncology community.

OMICS Group International is a leading Open Access publisher that publishes more than 700 leading-edge peer reviewed Open Access Journals and organizes over 1000 International Conferences globally with the support of nearly 1000 International Societies. OMICS International journals cater to over 3 million readers with the support of 50000 eminent personalities as editorial board member.

The main aim of the Journal of Cancer Clinical Trials is to publish high quality research works and provide Open Access to the articles using this platform. The Journal offers a rapid and time bound review and publication that freely disseminates research findings related to Cancer & clinical trials. Cancer Clinical Trials Journal caters to the requirements of the medical practitioners, researchers, lab professionals, students, academicians, and industry that is involved in Medical and clinical studies. No matter how prestigious or popular; it increases the visibility and impact of published work. It increases convenience, reach, and retrieval power. Free online literature software facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and Cancer Clinical Trials analysis.

A Cancer clinical trial involves the healthy people and cancer patients to test safety and efficacy of newly developed cancer drugs. Clinical trials are conducted for new effective medications. Clinical trials are conducted at different cancer hospitals. These studies help in diagnosing and treatment of cancer. A cancer clinical trial can also be said to be as a cancer clinical study.

Manuscripts can be uploaded online at Editorial Tracking System (https://www.scholarscentral.org/submissions/cancer-clinical-trials.html) or forwarded to the Editorial Office   cancer@peerjournal.org

Media Contact:

Rebecca J
Assistant Editorial Manager
Journal of Cancer Clinical Trials
Whatsapp No:  +1-504-608-2390
Email:  cancer@eclinicalsci.com